| Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer N Seubert, Y Royer, J Staerk, KF Kubatzky, V Moucadel, S Krishnakumar, ... Molecular cell 12 (5), 1239-1250, 2003 | 234 | 2003 |
| Chronic implant-related bone infections–can immune modulation be a therapeutic strategy? E Seebach, KF Kubatzky Frontiers in Immunology 10, 1724, 2019 | 148 | 2019 |
| Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor KF Kubatzky, W Ruan, R Gurezka, J Cohen, R Ketteler, SS Watowich, ... Current Biology 11 (2), 110-115, 2001 | 138 | 2001 |
| Conceptual Evolution of Cell Signaling A Nair, P Chauhan, B Saha, KF Kubatzky International journal of molecular sciences 20 (13), 3292, 2019 | 127 | 2019 |
| S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll‐like receptor 4 D Rohde, C Schön, M Boerries, I Didrihsone, J Ritterhoff, KF Kubatzky, ... EMBO molecular medicine 6 (6), 778-794, 2014 | 89 | 2014 |
| An Update on Interleukin-9: From Its Cellular Source and Signal Transduction to Its Role in Immunopathogenesis S Chakraborty, KF Kubatzky, DK Mitra International journal of molecular sciences 20 (9), 2113, 2019 | 75 | 2019 |
| Pasteurella multocida and Immune Cells KF Kubatzky Pasteurella multocida, 53-72, 2012 | 64 | 2012 |
| Structural requirements of the extracellular to transmembrane domain junction for erythropoietin receptor function KF Kubatzky, W Liu, K Goldgraben, C Simmerling, SO Smith, ... Journal of Biological Chemistry 280 (15), 14844-14854, 2005 | 60 | 2005 |
| Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation T Ginter, C Bier, SK Knauer, K Sughra, D Hildebrand, T Münz, T Liebe, ... Cellular signalling 24 (7), 1453-1460, 2012 | 53 | 2012 |
| Granzyme A produces bioactive IL-1β through a nonapoptotic inflammasome-independent pathway D Hildebrand, KA Bode, D Rieß, D Cerny, A Waldhuber, F Römmler, ... Cell reports 9 (3), 910-917, 2014 | 49 | 2014 |
| Pasteurella multocida toxin is a potent activator of anti‐apoptotic signalling pathways I Preuß, D Hildebrand, JHC Orth, K Aktories, KF Kubatzky Cellular microbiology 12 (8), 1174-1185, 2010 | 47 | 2010 |
| From macrophage to osteoclast–How metabolism determines function and activity KF Kubatzky, F Uhle, T Eigenbrod Cytokine 112, 102-115, 2018 | 46 | 2018 |
| The small GTPase RhoH is an atypical regulator of haematopoietic cells F Fueller, KF Kubatzky Cell Communication and Signaling 6 (1), 6, 2008 | 46 | 2008 |
| Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin JHC Orth, K Aktories, KF Kubatzky Journal of Biological Chemistry 282 (5), 3050-3057, 2007 | 45 | 2007 |
| Regulation of Toll-like receptor 4-mediated immune responses through Pasteurella multocida toxin-induced G protein signalling D Hildebrand, A Sahr, SJ Wölfle, K Heeg, KF Kubatzky Cell Communication and Signaling 10 (1), 22, 2012 | 38 | 2012 |
| The erythropoietin receptor transmembrane domain mediates complex formation with viral anemic and polycythemic gp55 proteins SN Constantinescu, T Keren, WP Russ, I Ubarretxena-Belandia, Y Malka, ... Journal of Biological Chemistry 278 (44), 43755-43763, 2003 | 36 | 2003 |
| The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression MS Gündogdu, H Liu, D Metzdorf, D Hildebrand, M Aigner, K Aktories, ... Molecular cancer 9 (1), 225, 2010 | 30 | 2010 |
| Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent D Hildebrand, K Heeg, KF Kubatzky Infection and immunity 79 (1), 220-228, 2011 | 29 | 2011 |
| Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells K Noack, N Mahendrarajah, D Hennig, L Schmidt, F Grebien, ... Archives of toxicology 91 (5), 2191-2208, 2017 | 26 | 2017 |
| Signaling cascades of Pasteurella multocida toxin in immune evasion K Kubatzky, B Kloos, D Hildebrand Toxins 5 (9), 1664-1681, 2013 | 26 | 2013 |
Klaus Heegpreviously: Heidelberg University Hospital - Department of Infectious Diseases
